Praxis Precision Medicines, Inc.PRAXNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank93
5Y CAGR-20.5%
Year-over-Year Change
Year-over-year SG&A expense growth
5Y CAGR
-20.5%/yr
Long-term compound
Percentile
P93
Near historical high
vs 5Y Ago
0.3x
Contraction
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 55.53% |
| Q3 2025 | -3.82% |
| Q2 2025 | -6.18% |
| Q1 2025 | -7.99% |
| Q4 2024 | -0.82% |
| Q3 2024 | 44.13% |
| Q2 2024 | -30.97% |
| Q1 2024 | 54.36% |
| Q4 2023 | 13.86% |
| Q3 2023 | -13.85% |
| Q2 2023 | -23.69% |
| Q1 2023 | 4.29% |
| Q4 2022 | -8.14% |
| Q3 2022 | -15.41% |
| Q2 2022 | 1.09% |
| Q1 2022 | 6.94% |
| Q4 2021 | 30.19% |
| Q3 2021 | 7.67% |
| Q2 2021 | 13.86% |
| Q1 2021 | 0.53% |
| Q4 2020 | 175.14% |
| Q3 2020 | 36.15% |
| Q2 2020 | 57.40% |
| Q1 2020 | -10.81% |
| Q4 2019 | 37.23% |
| Q3 2019 | -16.40% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |